Clinical Trials Browser

Phase 1/2 × Metastatic Castration-resistant Prostate Cancer (mCRPC) × Clear all

NCT07310355 2025-12-30

68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

Phase 1/2 Not yet recruiting

Metastatic Castration-resistant Prostate Cancer (mCRPC)

NCT07104617 2025-08-05

Study of TY-302 Capsules Combined With Abiraterone in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）

Phase 1/2 Not yet recruiting

Metastatic Castration-resistant Prostate Cancer (mCRPC)